Renin-angiotensin-aldosterone system blockade in critically ill patients is associated with increased risk for acute kidney injury

Tohoku Journal of Experimental Medicine

Volumn 238, Issue 1, 2015, Pages 17-23

  Lim, Hye Jin ^a   Lee, Hyun Hee ^a   Kim, Ae Jin ^a   Ro, Han ^a   Kim, Hyung Soo ^a   Chang, Jae Hyun ^a   Chung, Wookyung ^a   Jung, Ji Yong ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

Acute kidney injury; Intensive care unit; Mortality; Outcomes; Renin angiotensin aldosterone system blocker

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION; HUMAN; HYPERTENSION; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; ACUTE KIDNEY INJURY; CRITICAL ILLNESS; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICAL MODEL;

ACUTE KIDNEY INJURY; CRITICAL ILLNESS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SURVIVAL RATE;

EID: 84949570653     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.238.17     Document Type: Article

References (30)

1. Anathhanam, S. & Lewington, A.J. (2013) Acute kidney injury. J. R. Coll. Physicians Edinb., 43, 323-328.
2. Arora, P., Rajagopalam, S., Ranjan, R., Kolli, H., Singh, M., Venuto, R. & Lohr, J. (2008) Preoperative use of angiotensinconverting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin. J. Am. Soc. Nephrol., 3, 1266- 1273.
3. Bagshaw, S.M., Mortis, G., Doig, C.J., Godinez-Luna, T., Fick, G.H. & Laupland, K.B. (2006) One-year mortality in critically ill patients by severity of kidney dysfunction: a population- based assessment. Am. J. Kidney Dis., 48, 402-409.
4. Blanco, J., Muriel-Bombin, A., Sagredo, V., Taboada, F., Gandia, F., Tamayo, L., Collado, J., Garcia-Labattut, A., Carriedo, D., Valledor, M., De Frutos, M., Lopez, M.J., Caballero, A., Guerra, J., Alvarez, B., et al. (2008) Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit. Care, 12, R158.
5. Casas, J.P., Chua, W., Loukogeorgakis, S., Vallance, P., Smeeth, L., Hingorani, A.D. & MacAllister, R.J. (2005) Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet, 366, 2026-2033.
6. Chertow, G.M., Soroko, S.H., Paganini, E.P., Cho, K.C., Himmelfarb, J., Ikizler, T.A. & Mehta, R.L. (2006) Mortality after acute renal failure: models for prognostic stratification and risk adjustment. Kidney Int., 70, 1120-1126.
7. Cittanova, M.L., Zubicki, A., Savu, C., Montalvan, C., Nefaa, N., Zaier, K., Riou, B. & Coriat, P. (2001) The chronic inhibition of angiotensin-converting enzyme impairs postoperative renal function. Anesth. Analg., 93, 1111-1115.
8. de Mendonca, A., Vincent, J.L., Suter, P.M., Moreno, R., Dearden, N.M., Antonelli, M., Takala, J., Sprung, C. & Cantraine, F. (2000) Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med., 26, 915-921.
9. Gupta, R., Gurm, H.S., Bhatt, D.L., Chew, D.P. & Ellis, S.G. (2005) Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter. Cardiovasc. Interv., 64, 442-448.
10. Hobson, C.E., Yavas, S., Segal, M.S., Schold, J.D., Tribble, C.G., Layon, A.J. & Bihorac, A. (2009) Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation, 119, 2444-2453.
11. Hoste, E.A., Clermont, G., Kersten, A., Venkataraman, R., Angus, D.C., De Bacquer, D. & Kellum, J.A. (2006) RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit. Care, 10, R73.
12. Hou, S.H., Bushinsky, D.A., Wish, J.B., Cohen, J.J. & Harrington, J.T. (1983) Hospital-acquired renal insufficiency: a prospective study. Am. J. Med., 74, 243-248.
13. Kellum, J.A. (2002) The Acute Dialysis Quality Initiative: methodology. Adv. Ren. Replace. Ther., 9, 245-247. Kidney Disease: Improving Global Outcomes (KDIGO) Work
14. Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl., 2, 1-138.
15. Lafrance, J.P. & Miller, D.R. (2010) Acute kidney injury associates with increased long-term mortality. J. Am. Soc. Nephrol., 21, 345-352.
16. Lakhdar, R., Al-Mallah, M.H. & Lanfear, D.E. (2008) Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials. J. Card. Fail., 14, 181-188.
17. Loef, B.G., Epema, A.H., Smilde, T.D., Henning, R.H., Ebels, T., Navis, G. & Stegeman, C.A. (2005) Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J. Am. Soc. Nephrol., 16, 195-200.
18. Matchar, D.B., McCrory, D.C., Orlando, L.A., Patel, M.R., Patel, U.D., Patwardhan, M.B., Powers, B., Samsa, G.P. & Gray, R.N. (2008) Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann. Intern. Med., 148, 16-29.
19. Morgera, S., Schneider, M. & Neumayer, H.H. (2008) Long-term outcomes after acute kidney injury. Crit. Care Med., 36, S193-197.
20. National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Work Group (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis., 39, S1-266.
21. Plataki, M., Kashani, K., Cabello-Garza, J., Maldonado, F., Kashyap, R., Kor, D.J., Gajic, O. & Cartin-Ceba, R. (2011) Predictors of acute kidney injury in septic shock patients: an observational cohort study. Clin. J. Am. Soc. Nephrol., 6, 1744-1751.
22. Rim, M.Y., Ro, H., Kang, W.C., Kim, A.J., Park, H., Chang, J.H., Lee, H.H., Chung, W. & Jung, J.Y. (2012) The effect of reninangiotensin- aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study. Am. J. Kidney Dis., 60, 576-582.
23. Schoolwerth, A.C., Sica, D.A., Ballermann, B.J. & Wilcox, C.S. (2001) Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation, 104, 1985-1991.
24. Sileanu, F.E., Murugan, R., Lucko, N., Clermont, G., Kane-Gill, S.L., Handler, S.M. & Kellum, J.A. (2015) AKI in low-risk versus high-risk patients in intensive care. Clin. J. Am. Soc. Nephrol., 10, 187-196.
25. Stojiljkovic, L. & Behnia, R. (2007) Role of renin angiotensin system inhibitors in cardiovascular and renal protection: a lesson from clinical trials. Curr. Pharm. Des., 13, 1335-1345.
26. Toto, R. (2001) Angiotensin II subtype 1 receptor blockers and renal function. Arch. Intern. Med., 161, 1492-1499.
27. Uchino, S., Kellum, J.A., Bellomo, R., Doig, G.S., Morimatsu, H., Morgera, S., Schetz, M., Tan, I., Bouman, C., Macedo, E., Gibney, N., Tolwani, A. & Ronco, C. (2005) Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA, 294, 813-818.
28. Vivino, G., Antonelli, M., Moro, M.L., Cottini, F., Conti, G., Bufi, M., Cannata, F. & Gasparetto, A. (1998) Risk factors for acute renal failure in trauma patients. Intensive Care Med., 24, 808-814.
29. Wang, A.Y., Bellomo, R., Ninomiya, T., Lo, S., Cass, A., Jardine, M. & Gallagher, M. (2014) Angiotensin-converting enzyme inhibitor usage and acute kidney injury: a secondary analysis of RENAL study outcomes. Nephrology, 19, 617-622.
30. Winkelmayer, W.C., Fischer, M.A., Schneeweiss, S., Levin, R. & Avorn, J. (2006) Angiotensin inhibition after myocardial infarction: does drug class matter? J. Gen. Intern. Med., 21, 1242-1247.